Metric Finance
LearnFAQ
LearnFAQ

Learn / TLX

NASDAQ: TLX

Telix Pharmaceuticals Ltd (TLX) stock, explained like you're 5

Telix Pharmaceuticals Ltd trades on the Nasdaq under the ticker TLX. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 3.8 billion dollars.

Ticker
TLX
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Mid cap, about 3.8 billion dollars

Is Telix Pharmaceuticals Ltd a small, medium or large cap company?

No. Telix Pharmaceuticals Ltd is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 3.8 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Telix Pharmaceuticals Ltd makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves TLX stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Telix Pharmaceuticals Limited (TLX.AX) stock price, news, quote and history (Yahoo Finance Australia)
  • Telix Pharmaceuticals (ASX:TLX) Stock Forecast & Analyst Predictions (Simply Wall Street)
  • Telix Pharmaceuticals Limited (TLX) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • Telix Pharmaceuticals Stock Surges Toward 52 Week Highs as First Half Profit Surges 146% on Strong Precision Medicine Demand (TIKR.com)
  • Telix Pharmaceuticals' (TLX) Buy Rating Reiterated at HC Wainwright (MarketBeat)

Follow TLX in your daily brief

Each trading day at 5 PM ET we post what happened to Telix Pharmaceuticals Ltd and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow TLX

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Telix Pharmaceuticals Ltd stock

What does Telix Pharmaceuticals Ltd do?

Telix Pharmaceuticals Ltd trades on the Nasdaq under the ticker TLX. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 3.8 billion dollars.

What is the ticker symbol for Telix Pharmaceuticals Ltd?

Telix Pharmaceuticals Ltd trades under the ticker TLX on the Nasdaq.

What is Telix Pharmaceuticals Ltd's market cap?

Telix Pharmaceuticals Ltd is a mid cap stock with a market cap of about 3.8 billion dollars.

How does Telix Pharmaceuticals Ltd make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves TLX stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow TLX stock every day?

Add TLX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow TLX daily

A free brief on Telix Pharmaceuticals Ltd and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare TLX: TLX vs NVS, TLX vs AZN, TLX vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed